John Noseworthy Purchases Shares of UnitedHealth Group

On June 23, 2026, John Noseworthy, an insider at UnitedHealth Group Incorporated (NYSE: UNH), bought 41 shares. This transaction was not part of a pre-arranged trading plan, known as Rule 10b5-1. The purchase adds to the activity of insiders at the company, as several others, including CEO Stephen Hemsley, also acquired shares on the same day.

Insider Buying and Selling at UnitedHealth Group Incorporated

In addition to John Noseworthy, several other UnitedHealth insiders bought shares on June 23, 2026. These include Stephen Hemsley, the CEO, who purchased 46 shares, and Christopher Zaetta, the Executive Vice President and Chief Legal Officer, who bought 61 shares. Other insiders, such as Frederick McNabb III and Timothy Flynn, also participated in buying activity, each acquiring shares in the company.

UnitedHealth Group Incorporated Stock Up 5.7%

Shares of UnitedHealth Group (NYSE: UNH) traded near $415.53 on Friday. The company boasts a market capitalization of approximately $369.3 billion. UnitedHealth has a price-to-earnings (P/E) ratio of 30.6 and a forward P/E of 19.4, indicating expectations for future earnings growth. The stock's 52-week range has been between $234.60 and $415.98, with a 50-day moving average of $372.67 and a 200-day moving average of $333.55.

Analysts Set New Price Targets

On June 24, 2026, B of A Securities maintained its 'buy' rating for UnitedHealth Group, setting a price target of $475. Other firms like Leerink Partners and Mizuho have also maintained 'buy' ratings, with targets of $462 and $460, respectively. The consensus among analysts is a 'buy' recommendation, with a mean price target of around $409.77 based on 26 analyst opinions.

About UnitedHealth Group

UnitedHealth Group Incorporated is a leading healthcare company based in Eden Prairie, Minnesota. It operates through several segments, including Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare. The company provides a wide range of health-related services and products, from pharmacy care to health benefit plans. With a workforce of 390,000 employees, UnitedHealth is a major player in the healthcare sector, serving both U.S. and international markets.

Bottom Line

John Noseworthy's recent purchase of UnitedHealth shares is part of broader insider buying activity at the company. UnitedHealth's stock is trading near its 52-week high, reflecting strong market confidence. With analysts consistently rating the stock as a 'buy', the company remains a focal point for investors in the healthcare sector. As always, it's important to remember that insider transactions are just one of many factors investors consider, and they reflect past actions rather than current intentions.